Maternal IgG Antibodies to SARS-CoV-2 Transferred Across Placenta
MONDAY, Feb. 1, 2021 -- Maternal immunoglobulin (Ig)G antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are transferred across the placenta, and cord blood IgG concentrations are associated with maternal IgG concentrations, according to a study published online Jan. 29 in JAMA Pediatrics.
Dustin D. Flannery, D.O., from the Children's Hospital of Philadelphia, and colleagues examined the correlation between maternal and neonatal SARS-CoV-2-specific antibody concentrations in a cohort study involving 1,714 women who delivered between April 9 and Aug. 8, 2020. Antibody measurements were taken from maternal and cord blood sera for 1,471 mother/newborn dyads.
The researchers detected SARS-CoV-2 IgG and/or IgM antibodies in 83 of 1,471 women (6 percent) at the time of delivery; in 72 of 83 newborns (87 percent), IgG was detected in cord blood, while IgM was not detected in any cord blood specimens. No antibodies were detected in infants born to seronegative mothers. Eleven infants born to seropositive mothers were seronegative, including five born to mothers with IgM antibodies only and six born to mothers with significantly lower IgG concentrations compared with mothers of seropositive infants. There was a positive correlation for cord blood IgG concentrations with maternal IgG concentrations. Women with asymptomatic SARS-CoV-2 infections and those with mild, moderate, and severe COVID-19 had placental transfer rates of more than 1.0.
"Our findings demonstrate the potential for maternally derived antibodies to provide neonatal protection from SARS-CoV-2 infection and will help inform both neonatal management guidance and design of vaccine trials during pregnancy," the authors write.
One author disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
THURSDAY, Feb. 25, 2021 -- Low disease activity and remission are feasible goals for women with rheumatoid arthritis (RA) cared for with a modern treatment approach during...
THURSDAY, Feb. 25, 2021 -- For women aged younger than 65 years, the mortality gap between cancer and heart disease is narrowing, according to a study published online Feb. 8 in...
THURSDAY, Feb. 25, 2021 -- Negative changes in brain volumes and cognitive scores persist over time in children with early-onset type 1 diabetes, according to a study published...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.